Markowitz Wayne, CVP of JAPAC at Edwards Lifesciences Corp ($EW), made two open market sales of EW stock over the past year, totaling $70,265. His latest sale occurred on December 8, 2025. These transactions rank 10,023rd among 11,678 insiders by sale value, well below the average of $8.6 million across 6.4 sales per insider. Wayne Markowitz recorded no open market purchases.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec. 8, 2025 | Edwards Lifesciences Corp | $EW | Markowitz Wayne | CVP, JAPAC | S | Common Stock | 583 | $86.01 | 17,562.8708 | 658,200,000 | 3.21% | 0.00% |
| Sept. 14, 2025 | Edwards Lifesciences Corp | $EW | Markowitz Wayne | CVP, JAPAC | F | Common Stock | 650 | $77.57 | 18,145.8708 | 657,600,000 | 3.46% | 0.00% |
| Sept. 11, 2025 | Edwards Lifesciences Corp | $EW | Markowitz Wayne | CVP, JAPAC | A | Common Stock | 6410 | $0.00 | 18,795.8708 | 657,600,000 | 51.75% | 0.00% |
| May 8, 2025 | Edwards Lifesciences Corp | $EW | Markowitz Wayne | GM & SVP, Surgical | A | Employee Stock Option (Right to Acquire) | 17100 | $0.00 | 17,100.0000 | 655,900,000 | 9999.99% | 0.00% |
| May 8, 2025 | Edwards Lifesciences Corp | $EW | Markowitz Wayne | GM & SVP, Surgical | A | Performance Rights | 3350 | $0.00 | 3,350.0000 | 655,900,000 | 9999.99% | 0.00% |
| May 7, 2025 | Edwards Lifesciences Corp | $EW | Markowitz Wayne | GM & SVP, Surgical | S | Common Stock | 268 | $75.08 | 9,299.1916 | 655,900,000 | 2.80% | 0.00% |
| May 7, 2025 | Edwards Lifesciences Corp | $EW | Markowitz Wayne | GM & SVP, Surgical | F | Common Stock | 300 | $74.92 | 8,999.1916 | 655,900,000 | 3.23% | 0.00% |
| May 8, 2025 | Edwards Lifesciences Corp | $EW | Markowitz Wayne | GM & SVP, Surgical | A | Common Stock | 3350 | $0.00 | 12,349.1916 | 655,900,000 | 37.23% | 0.00% |
| Dec. 6, 2024 | Edwards Lifesciences Corp | $EW | Markowitz Wayne | GM & SVP, Surgical | S | Common Stock | 583 | $73.27 | 9,493.8468 | 654,300,000 | 5.79% | 0.00% |
| Sept. 14, 2024 | Edwards Lifesciences Corp | $EW | Markowitz Wayne | GM & SVP, Surgical | F | Common Stock | 648 | $68.52 | 10,033.0463 | 653,500,000 | 6.07% | 0.00% |
| May 7, 2024 | Edwards Lifesciences Corp | $EW | Markowitz Wayne | GM & SVP, Surgical | A | Employee Stock Option (Right to Acquire) | 17800 | $0.00 | 17,800.0000 | 651,800,000 | 9999.99% | 0.00% |
| May 7, 2024 | Edwards Lifesciences Corp | $EW | Markowitz Wayne | GM & SVP, Surgical | A | Performance Rights | 3350 | $0.00 | 3,350.0000 | 651,800,000 | 9999.99% | 0.00% |
| May 7, 2024 | Edwards Lifesciences Corp | $EW | Markowitz Wayne | GM & SVP, Surgical | A | Common Stock | 3350 | $0.00 | 10,648.5547 | 651,800,000 | 45.90% | 0.00% |